BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2788271)

  • 1. The use of alpha-aminoboronic acid derivatives to stabilize peptide drugs during their intranasal absorption.
    Hussain MA; Shenvi AB; Rowe SM; Shefter E
    Pharm Res; 1989 Feb; 6(2):186-9. PubMed ID: 2788271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recovery of rat nasal mucosa from the effects of aminopeptidase inhibitors.
    Hussain MA; Koval CA; Shenvi AB; Aungst BJ
    J Pharm Sci; 1990 May; 79(5):398-400. PubMed ID: 2352157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An aminoboronic acid derivative inhibits thymopentin metabolism by mucosal membrane aminopeptidases.
    Hussain MA; Koval CA; Shenvi AB; Aungst BJ
    Life Sci; 1990; 47(3):227-31. PubMed ID: 2201862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrolysis of leucine enkephalin in the nasal cavity of the rat--a possible factor in the low bioavailability of nasally administered peptides.
    Hussain A; Faraj J; Aramaki Y; Truelove JE
    Biochem Biophys Res Commun; 1985 Dec; 133(3):923-8. PubMed ID: 4084310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of leucine enkephalin metabolism in rat blood, plasma and tissues in vitro by an aminoboronic acid derivative.
    Hussain MA; Rowe SM; Shenvi AB; Aungst BJ
    Drug Metab Dispos; 1990; 18(3):288-91. PubMed ID: 2143133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of human nasal primary culture systems to investigate peptide metabolism.
    Hoang VD; Uchenna AR; Mark J; Renaat K; Norbert V
    Int J Pharm; 2002 May; 238(1-2):247-56. PubMed ID: 11996828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasal absorption enhancement strategies for therapeutic peptides: an in vitro study using cultured human nasal epithelium.
    Agu RU; Vu Dang H; Jorissen M; Willems T; Kinget R; Verbeke N
    Int J Pharm; 2002 Apr; 237(1-2):179-91. PubMed ID: 11955816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phosphinic acid dipeptide analogue to stabilize peptide drugs during their intranasal absorption.
    Hussain MA; Lim MS; Raghavan KS; Rogers NJ; Hidalgo R; Kettner CA
    Pharm Res; 1992 May; 9(5):626-8. PubMed ID: 1608893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal absorption of leucine enkephalin in rats and the effects of aminopeptidase inhibition, as determined from the percentage of the dose unabsorbed.
    Hussain MA; Aungst BJ
    Pharm Res; 1992 Oct; 9(10):1362-4. PubMed ID: 1448440
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanism of nasal absorption of drugs. III: Nasal absorption of leucine enkephalin.
    Faraj JA; Hussain AA; Aramaki Y; Iseki K; Kagoshima M; Dittert LW
    J Pharm Sci; 1990 Aug; 79(8):698-702. PubMed ID: 2231332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of aminopeptidases from Aplysia californica.
    Bawab W; Querido E; Crine P; DesGroseillers L
    Biochem J; 1992 Sep; 286 ( Pt 3)(Pt 3):967-75. PubMed ID: 1417757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro evaluation of the potential of thiomers for the nasal administration of Leu-enkephalin.
    Bernkop-Schnürch A; Obermair K; Greimel A; Palmberger TF
    Amino Acids; 2006 Jun; 30(4):417-23. PubMed ID: 16554973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enkephalin degradation in the guinea-pig ileum: effect of aminopeptidase inhibitors, puromycin and bestatin.
    Cohen ML; Geary LE; Wiley KS
    J Pharmacol Exp Ther; 1983 Feb; 224(2):379-85. PubMed ID: 6822962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug metabolism in the nasal mucosa.
    Sarkar MA
    Pharm Res; 1992 Jan; 9(1):1-9. PubMed ID: 1589391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. alpha-Aminoboronic acid derivatives: effective inhibitors of aminopeptidases.
    Shenvi AB
    Biochemistry; 1986 Mar; 25(6):1286-91. PubMed ID: 3516217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of enkephalin degrading enzymes by metal chelating reagents.
    Altstein M; Blumberg S; Vogel Z
    Adv Biochem Psychopharmacol; 1982; 33():261-70. PubMed ID: 6751033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmucosal delivery of leucine enkephalin: stabilization in rabbit enzyme extracts and enhancement of permeation through mucosae.
    Sayani AP; Chun IK; Chien YW
    J Pharm Sci; 1993 Nov; 82(11):1179-85. PubMed ID: 8289138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal delivery of polypeptides I: nasal absorption of enkephalins in rats.
    Su KS; Campanale KM; Mendelsohn LG; Kerchner GA; Gries CL
    J Pharm Sci; 1985 Apr; 74(4):394-8. PubMed ID: 3889275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analgesic effects of intra-nasal enkephalins.
    Gwak HS; Cho YM; Chun IK
    J Pharm Pharmacol; 2003 Sep; 55(9):1207-12. PubMed ID: 14604463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human plasma leucine5-enkephalin aminopeptidase hydrolysis by various endogenous peptides and a select number of clinically used drugs.
    Mosnaim AD; Puente J; Ranade V; Hoang C; Wolf ME
    Am J Ther; 2004; 11(6):459-65. PubMed ID: 15543085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.